228 related articles for article (PubMed ID: 10380930)
21. Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48.
Evans EJ; Castro MA; O'Brien R; Kearney A; Walsh H; Sparks LM; Tucknott MG; Davies EA; Carmo AM; van der Merwe PA; Stuart DI; Jones EY; Ladbury JE; Ikemizu S; Davis SJ
J Biol Chem; 2006 Sep; 281(39):29309-20. PubMed ID: 16803907
[TBL] [Abstract][Full Text] [Related]
22. A model for CD2/CD58-mediated adhesion strengthening.
Shao JY; Yu Y; Dustin ML
Ann Biomed Eng; 2005 Apr; 33(4):483-93. PubMed ID: 15909654
[TBL] [Abstract][Full Text] [Related]
23. Structural biology of the cell adhesion protein CD2: alternatively folded states and structure-function relation.
Yang JJ; Ye Y; Carroll A; Yang W; Lee HW
Curr Protein Pept Sci; 2001 Mar; 2(1):1-17. PubMed ID: 12369898
[TBL] [Abstract][Full Text] [Related]
24. Modulation of co-stimulatory signal from CD2-CD58 proteins by a grafted peptide.
Parajuli P; Sable R; Shrestha L; Dahal A; Gauthier T; Taneja V; Jois S
Chem Biol Drug Des; 2021 Mar; 97(3):607-627. PubMed ID: 32946175
[TBL] [Abstract][Full Text] [Related]
25. Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.
Sable R; Durek T; Taneja V; Craik DJ; Pallerla S; Gauthier T; Jois S
ACS Chem Biol; 2016 Aug; 11(8):2366-74. PubMed ID: 27337048
[TBL] [Abstract][Full Text] [Related]
26. Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58.
Gokhale A; Weldeghiorghis TK; Taneja V; Satyanarayanajois SD
J Med Chem; 2011 Aug; 54(15):5307-19. PubMed ID: 21755948
[TBL] [Abstract][Full Text] [Related]
27. CD2 and the nature of protein interactions mediating cell-cell recognition.
Davis SJ; Ikemizu S; Wild MK; van der Merwe PA
Immunol Rev; 1998 Jun; 163():217-36. PubMed ID: 9700513
[TBL] [Abstract][Full Text] [Related]
28. Low affinity binding of an LFA-3/IgG1 fusion protein to CD2+ T cells is independent of cell activation.
Majeau GR; Whitty A; Yim K; Meier W; Hochman PS
Cell Adhes Commun; 1999; 7(3):267-79. PubMed ID: 10626910
[TBL] [Abstract][Full Text] [Related]
29. Virtual Screening and Binding Analysis of Potential CD58 Inhibitors in Colorectal Cancer (CRC).
Guo R; Yu J; Guo Z
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836662
[TBL] [Abstract][Full Text] [Related]
30. Conformation and function of the N-linked glycan in the adhesion domain of human CD2.
Wyss DF; Choi JS; Li J; Knoppers MH; Willis KJ; Arulanandam AR; Smolyar A; Reinherz EL; Wagner G
Science; 1995 Sep; 269(5228):1273-8. PubMed ID: 7544493
[TBL] [Abstract][Full Text] [Related]
31. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
[TBL] [Abstract][Full Text] [Related]
32. Glycosylation Modulates Human CD2-CD58 Adhesion via Conformational Adjustment.
Wang X; Ji CG; Zhang JZ
J Phys Chem B; 2015 Jun; 119(22):6493-501. PubMed ID: 25984915
[TBL] [Abstract][Full Text] [Related]
33. MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells.
Nielsen M; Gerwien J; Geisler C; Röpke C; Svejgaard A; Odum N
Exp Clin Immunogenet; 1998; 15(2):61-8. PubMed ID: 9691200
[TBL] [Abstract][Full Text] [Related]
34. N-glycosylation is required for human CD2 immunoadhesion functions.
Recny MA; Luther MA; Knoppers MH; Neidhardt EA; Khandekar SS; Concino MF; Schimke PA; Francis MA; Moebius U; Reinhold BB
J Biol Chem; 1992 Nov; 267(31):22428-34. PubMed ID: 1385399
[TBL] [Abstract][Full Text] [Related]
35. Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot".
Kim M; Sun ZY; Byron O; Campbell G; Wagner G; Wang J; Reinherz EL
J Mol Biol; 2001 Sep; 312(4):711-20. PubMed ID: 11575926
[TBL] [Abstract][Full Text] [Related]
36. A novel monoclonal antibody inhibits the immune response of human cells against porcine cells: identification of a porcine antigen homologous to CD58.
Crosby K; Yatko C; Dersimonian H; Pan L; Edge AS
Transplantation; 2004 Apr; 77(8):1288-94. PubMed ID: 15114100
[TBL] [Abstract][Full Text] [Related]
37. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
38. The structure and ligand interactions of CD2: implications for T-cell function.
Davis SJ; van der Merwe PA
Immunol Today; 1996 Apr; 17(4):177-87. PubMed ID: 8871350
[No Abstract] [Full Text] [Related]
39. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity.
Dustin ML; Golan DE; Zhu DM; Miller JM; Meier W; Davies EA; van der Merwe PA
J Biol Chem; 1997 Dec; 272(49):30889-98. PubMed ID: 9388235
[TBL] [Abstract][Full Text] [Related]
40. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway.
Albert-Wolf M; Meuer SC; Wallich R
Int Immunol; 1991 Dec; 3(12):1335-47. PubMed ID: 1723296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
